Correlation Between X4 Pharmaceuticals and Sera Prognostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Sera Prognostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Sera Prognostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Sera Prognostics, you can compare the effects of market volatilities on X4 Pharmaceuticals and Sera Prognostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Sera Prognostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Sera Prognostics.

Diversification Opportunities for X4 Pharmaceuticals and Sera Prognostics

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between XFOR and Sera is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Sera Prognostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sera Prognostics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Sera Prognostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sera Prognostics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Sera Prognostics go up and down completely randomly.

Pair Corralation between X4 Pharmaceuticals and Sera Prognostics

Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 2.84 times more return on investment than Sera Prognostics. However, X4 Pharmaceuticals is 2.84 times more volatile than Sera Prognostics. It trades about 0.03 of its potential returns per unit of risk. Sera Prognostics is currently generating about -0.23 per unit of risk. If you would invest  73.00  in X4 Pharmaceuticals on November 1, 2024 and sell it today you would lose (4.30) from holding X4 Pharmaceuticals or give up 5.89% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

X4 Pharmaceuticals  vs.  Sera Prognostics

 Performance 
       Timeline  
X4 Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in X4 Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, X4 Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Sera Prognostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sera Prognostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

X4 Pharmaceuticals and Sera Prognostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with X4 Pharmaceuticals and Sera Prognostics

The main advantage of trading using opposite X4 Pharmaceuticals and Sera Prognostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Sera Prognostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sera Prognostics will offset losses from the drop in Sera Prognostics' long position.
The idea behind X4 Pharmaceuticals and Sera Prognostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges